No one expected that it was going to shut down the progression of Alzheimers disease, but there was a hope that we would see some benefit, and we didnt. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing
Rather than weakening effect, GLP-1 appetite control typically stabilizes and maintains effectiveness month after month
Once the FDA declared the shortage resolved, 503A pharmacies were ordered to stop dispensing compounded tirzepatide by February 18, 2025 , followed by 503B facilities on March 19, 2025
However, its available in select pharmacies
That means its passed earlier tests of basic safety and effectiveness, and researchers are now testing it in larger groups to confirm how well it works and whether its safe enough for doctors to prescribe
Flow cytometry and additional experimental approaches were employed to investigate the mechanisms of CD8 + T cell exhaustion